Anders Kvanta

Professor in ophthalmology and senior staff member in vitreoretinal surgery. 

We conduct experimental and clinical studies focused on identifying new treatments of retinal diseases, focusing on age-related and inherited retinal degenerations. Projects include molecular and cell biology studies, and development of preclinical models aimed for translation into development of novel gene- and cell therapies with the overall goal to restore lost vision. We lead an ongoing first-in-human clinical gene therapy trial for Bothnia dystrphy. In a joint project, we use differentiated embryonic stem cells to replace lost retinal cells in an attempt to treat retinal degenerations with a first-in-human clinical trial in development.